Cover Image

Molecular characterization of interdigitating dendritic cell sarcoma

Glen J. Weiss, Arlet Alarcon, Maqbool Halepota, Robert J. Penny, Daniel D. Von Hoff
  • Glen J. Weiss
    Virginia G. Piper Cancer Center at Scottsdale Healthcare/TGen, United States | gweiss@tgen.org
  • Arlet Alarcon
    Caris Life Sciences, United States
  • Maqbool Halepota
    Scottsdale Healthcare, United States
  • Robert J. Penny
    Caris Life Sciences, United States
  • Daniel D. Von Hoff
    Virginia G. Piper Cancer Center at Scottsdale Healthcare/TGen,

Abstract

Interdigitating dendritic cell sarcoma is an extremely rare cancer that lacks a standard treatment approach. We report on a patient who was surgically resected and remains disease-free. The tumor was assessed for druggable targets using immunohistochemical staining to identify potential agents that could be used in the event of disease recurrence.

Keywords

interdigitating dendritic cell sarcoma; SPARC; HSP90; treatment target

Full Text:

PDF
HTML
Submitted: 2010-05-14 19:19:11
Published: 2010-08-03 12:16:33
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
429

Views:
PDF
155
HTML
1124

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2010 Glen J. Weiss, Arlet Alarcon, Maqbool Halepota, Robert J. Penny, Daniel D. Von Hoff

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185